Publication | Closed Access

Second-Line Combination Chemotherapy with Docetaxel and Nedaplatin for Cisplatin-Pretreated Refractory Metastatic/Recurrent Esophageal Squamous Cell Carcinoma

Second-line Combination ChemotherapyEsophageal CancerMedicinePathologyCancer TreatmentOncologyRadiation OncologyMolecular Oncology